November 15, 2019
National Cancer Institute (NCI)
The purpose of this Notice is to inform interested applicants of a change to the Key Dates for PAR-20-052, "NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional)", which replaces PAR-18-021, "NCI Small Grants Program for Cancer Research (NCI Omnibus R03 Clinical Trial Optional)".
This Funding Opportunity Announcement has been modified to add the following AIDS Application Due Date (in italics).
Part 1. Overview Information, Key Dates
Currently reads:
Open Date (Earliest Submission Date): January 24, 2020
Modified to read (in italics)
Open Date (Earliest Submission Date): December 7 , 2019
Currently reads:
AIDS Application Due Date(s): May 7, 2020; September 7, 2020; January 7, 2021; May 7, 2021; September 7, 2021; January 7, 2022; May 7, 2022; September 7, 2022; January 7, 2023
Modified to read (in italics):
AIDS Application Due Date(s): January 7, 2020; May 7, 2020; September 7, 2020; January 7, 2021; May 7, 2021; September 7, 2021; January 7, 2022; May 7, 2022; September 7, 2022; January 7, 2023
All other aspects of this FOA remain unchanged.
Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: [email protected]